Literature DB >> 2857725

The effects of taxol, a microtubule-stabilizing drug, on steroidogenic cells.

W E Rainey, R E Kramer, J I Mason, J W Shay.   

Abstract

The effects of taxol on steroid production and microtubule polymerization were examined using Y-1 adrenocortical tumor cells, MLTC-1 Leydig tumor cells, and primary cultures of bovine adrenocortical cells. Taxol inhibited the following steroidogenic processes within the Y-1 and MLTC-1 cells: (1) hormonal increase of steroid production, (2) dibutyryl cyclic AMP-increased steroid production, and (3) hormone-stimulated pregnenolone production. The inhibitory action of taxol was concentration dependent and also resulted in an increase in cytoplasmic microtubules. In addition, the inhibitory action of taxol on hormone-stimulated steroid production was reversible. Taxol appeared to inhibit cholesterol movement to the mitochondrial site of cholesterol side-chain cleavage enzyme but did not affect overall protein synthesis. Interestingly, taxol did not affect hormone-stimulated steroid production in bovine adrenocortical cells. This lack of inhibition may correspond to the ultrastructural observation that microtubule bundling after taxol treatment was observed in the tumor cells but not in similarly treated bovine adrenal cells. With this conflicting information between cell types, a direct relationship between taxol treatment and inhibition of steroid production has not been established. However, these results suggest that taxol alters the rate of transport of cholesterol to the cholesterol side-chain cleavage enzyme within the steroidogenic tumor cells.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2857725     DOI: 10.1002/jcp.1041230104

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  6 in total

1.  RhoA and DIAPH1 mediate adrenocorticotropin-stimulated cortisol biosynthesis by regulating mitochondrial trafficking.

Authors:  Donghui Li; Marion B Sewer
Journal:  Endocrinology       Date:  2010-06-30       Impact factor: 4.736

Review 2.  Paclitaxel. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the treatment of cancer.

Authors:  C M Spencer; D Faulds
Journal:  Drugs       Date:  1994-11       Impact factor: 9.546

3.  Genetic heterogeneity beyond CYP2C8*3 does not explain differential sensitivity to paclitaxel-induced neuropathy.

Authors:  Daniel L Hertz; Siddharth Roy; John Jack; Alison A Motsinger-Reif; Amy Drobish; L Scott Clark; Lisa A Carey; E Claire Dees; Howard L McLeod
Journal:  Breast Cancer Res Treat       Date:  2014-04-06       Impact factor: 4.872

Review 4.  Regulation of adrenocortical steroid hormone production by RhoA-diaphanous 1 signaling and the cytoskeleton.

Authors:  Marion B Sewer; Donghui Li
Journal:  Mol Cell Endocrinol       Date:  2012-11-24       Impact factor: 4.102

Review 5.  Exploration of the Hypothalamic-Pituitary-Adrenal Axis to Improve Animal Welfare by Means of Genetic Selection: Lessons from the South African Merino.

Authors:  Denise Hough; Pieter Swart; Schalk Cloete
Journal:  Animals (Basel)       Date:  2013-05-17       Impact factor: 2.752

6.  Redefining metamorphosis in spiny lobsters: molecular analysis of the phyllosoma to puerulus transition in Sagmariasus verreauxi.

Authors:  Tomer Ventura; Quinn P Fitzgibbon; Stephen C Battaglene; Abigail Elizur
Journal:  Sci Rep       Date:  2015-08-27       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.